Shanghai Shyndec Pharmaceutical Co., Ltd.

XSSC:600420 Stock Report

Market Cap: CN¥16.4b

Shanghai Shyndec Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.

Key information

7.1%

Debt to equity ratio

CN¥1.08b

Debt

Interest coverage ratio-12.5x
CashCN¥5.64b
EquityCN¥15.19b
Total liabilitiesCN¥4.87b
Total assetsCN¥20.07b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).

Long Term Liabilities: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).


Debt to Equity History and Analysis

Debt Level: 600420 has more cash than its total debt.

Reducing Debt: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.

Debt Coverage: 600420's debt is well covered by operating cash flow (212.6%).

Interest Coverage: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies